On May 23, Gov. Mark Dayton vetoed SF 3656, the Omnibus Supplemental Finance bill. This veto means that SF 799d will not be enacted. The two bills included several items of consequence to pharmacy:
CMS Covered Outpatient Drug Rule for FFS Medicaid: pharmacy reimbursement rate, NADAQ + $10.48 and the 2% provider-wholesale tax fix; Task Force created to recommend to the legislature by February 1, 2019, a long-term solution to the outpatient prescription drug rule implementation.
Would prohibit pharmacy benefit manager gag orders in pharmacy contracts in Minnesota.
Health plans required to provide patient with the lowest cost of medication at the point of sale (co-pay claw-back prohibited).
Emergency fill and data input/output allowed remotely.
Minnesota Opioid Stewardship Council – includes MN pharmacy representative.
It is unclear what the next steps will be for the CMS Covered Outpatient Drug Rule and other vetoed measures. The governor has previously stated that he will not call a special session. PATF Lobbyist Buck Humphrey reports that an aide to the governor, Jennifer McNerney, has repeated that stance.